BDNF and myeloid sarcoma: To this purpose, we have firstly investigate the main potential targets of MS-related impairments, in particular the cognitive deficits, focusing on the alteration of biomarkers such as BDNF and the Tryptophan/Kynurenine ratio whose neuroprotective metabolites can be modulated by nutritional approaches.